Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CODX NASDAQ:FEMY NASDAQ:MHUA NASDAQ:TIVC On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCODXCo-Diagnostics$0.34-0.8%$0.29$0.23▼$1.40$13.14M0.78972,582 shs599,700 shsFEMYFemasys$0.39+6.8%$0.70$0.31▼$1.80$12.78M-2.632.81 million shs1.22 million shsMHUAMeihua International Medical Technologies$0.48+13.9%$0.41$0.25▼$1.24$15.44M0.79138,832 shs542,876 shsTIVCTivic Health Systems$3.11+1.3%$3.51$2.43▼$15.64$3.36M1.97833,301 shs22,061 shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCODXCo-Diagnostics0.00%+10.10%+15.94%+25.87%-73.96%FEMYFemasys0.00%+4.31%-44.78%-56.91%-64.99%MHUAMeihua International Medical Technologies0.00%+32.58%+24.40%+30.78%-54.78%TIVCTivic Health Systems0.00%+5.78%-17.94%-17.07%-36.08%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCODXCo-Diagnostics$0.34-0.8%$0.29$0.23▼$1.40$13.14M0.78972,582 shs599,700 shsFEMYFemasys$0.39+6.8%$0.70$0.31▼$1.80$12.78M-2.632.81 million shs1.22 million shsMHUAMeihua International Medical Technologies$0.48+13.9%$0.41$0.25▼$1.24$15.44M0.79138,832 shs542,876 shsTIVCTivic Health Systems$3.11+1.3%$3.51$2.43▼$15.64$3.36M1.97833,301 shs22,061 shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCODXCo-Diagnostics0.00%+10.10%+15.94%+25.87%-73.96%FEMYFemasys0.00%+4.31%-44.78%-56.91%-64.99%MHUAMeihua International Medical Technologies0.00%+32.58%+24.40%+30.78%-54.78%TIVCTivic Health Systems0.00%+5.78%-17.94%-17.07%-36.08%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCODXCo-Diagnostics 3.00Buy$5.501,512.43% UpsideFEMYFemasys 3.00Buy$7.331,770.27% UpsideMHUAMeihua International Medical Technologies 0.00N/AN/AN/ATIVCTivic Health Systems 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest TIVC, MHUA, FEMY, and CODX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/15/2025CODXCo-DiagnosticsD. Boral CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$10.008/11/2025FEMYFemasysHC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$12.00 ➝ $8.006/25/2025FEMYFemasysHC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$12.00(Data available from 9/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCODXCo-Diagnostics$3.91M3.36N/AN/A$1.70 per share0.20FEMYFemasys$1.63M7.84N/AN/A$0.10 per share3.92MHUAMeihua International Medical Technologies$96.90M0.16$0.45 per share1.07$6.34 per share0.08TIVCTivic Health Systems$780K4.31N/AN/A$4.55 per share0.68Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCODXCo-Diagnostics-$37.64M-$1.15N/AN/AN/A-3,588.33%-69.49%-60.49%11/6/2025 (Estimated)FEMYFemasys-$18.82M-$0.86N/AN/AN/A-1,113.72%-713.74%-152.60%11/11/2025 (Estimated)MHUAMeihua International Medical Technologies$10.84MN/A0.00∞N/AN/AN/AN/AN/ATIVCTivic Health SystemsN/AN/A0.00∞N/A-148.49%-22.69%-18.94%N/ALatest TIVC, MHUA, FEMY, and CODX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/14/2025Q2 2025CODXCo-Diagnostics-$0.25-$0.23+$0.02-$0.23$0.30 million$0.16 million8/14/2025Q2 2025TIVCTivic Health SystemsN/A-$2.19N/A-$2.19N/A$0.09 million8/8/2025Q2 2025FEMYFemasys-$0.18-$0.16+$0.02-$0.16$0.80 million$0.41 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCODXCo-DiagnosticsN/AN/AN/AN/AN/AFEMYFemasysN/AN/AN/AN/AN/AMHUAMeihua International Medical TechnologiesN/AN/AN/AN/AN/ATIVCTivic Health SystemsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCODXCo-DiagnosticsN/A4.123.83FEMYFemasys0.030.890.41MHUAMeihua International Medical TechnologiesN/A5.265.21TIVCTivic Health SystemsN/A2.241.90Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCODXCo-Diagnostics14.99%FEMYFemasys65.27%MHUAMeihua International Medical Technologies1.17%TIVCTivic Health Systems4.25%Insider OwnershipCompanyInsider OwnershipCODXCo-Diagnostics6.10%FEMYFemasys11.54%MHUAMeihua International Medical Technologies66.56%TIVCTivic Health Systems0.51%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCODXCo-Diagnostics10038.52 million36.17 millionOptionableFEMYFemasys3032.58 million28.82 millionNot OptionableMHUAMeihua International Medical Technologies62031.90 million10.67 millionNot OptionableTIVCTivic Health Systems101.08 million1.08 millionNot OptionableTIVC, MHUA, FEMY, and CODX HeadlinesRecent News About These CompaniesTivic Completes Verification of Entolimod™ Cell Line: First Step in Establishing CGMP Manufacturing for BLA FilingSeptember 11, 2025 | finance.yahoo.comTivic Health’s Mixed Q2 2025 Earnings Call: Biopharma FocusAugust 31, 2025 | tipranks.comTivic Health Systems Appoints New Transfer AgentAugust 27, 2025 | tipranks.comTivic Receives Two Investigational New Drug Applications for Entolimod™ for the Treatment of Acute Radiation Syndrome (ARS) and Advanced CancersAugust 20, 2025 | businesswire.comTivic Health stock soars as company advances military radiation countermeasureAugust 15, 2025 | investing.comTivic Health Advances Discussions on Use of Entolimod as a Radiation Countermeasure at Military Health System Research Symposium 2025August 15, 2025 | businesswire.comTivic Health Systems, Inc. (TIVC) Q2 2025 Earnings Call TranscriptAugust 14, 2025 | seekingalpha.comTivic Health Sales Drop 39 PercentAugust 14, 2025 | aol.comATivic Health (TIVC) Q2 2025 Earnings TranscriptAugust 14, 2025 | fool.comTivic Reports Second Quarter 2025 Financial ResultsAugust 14, 2025 | businesswire.comTivic Health stock rises after shareholders approve strategic proposalsJuly 8, 2025 | in.investing.comTivic Shareholders Approve Key Proposals in Support of Strategic Transformation; Lisa Wolf Appointed Permanent CFOJuly 8, 2025 | finance.yahoo.comTivic Health Shares Gain Following Shareholder Approval of Strategic MovesJuly 8, 2025 | msn.comTivic Health Systems Inc (TIVC) - Investing.comJuly 5, 2025 | investing.comTivic Health Systems Inc News (TIVC) - Investing.comJuly 1, 2025 | investing.comTivic Health Completes Optimization Study for Its Non-Invasive Vagus Nerve Stimulation Device - Business WireJune 26, 2025 | businesswire.comTivic Health Completes Optimization Study for Its Non-Invasive Vagus Nerve Stimulation DeviceJune 25, 2025 | businesswire.comTivic Health Systems, Inc. (TIVC) - Yahoo FinanceJune 24, 2025 | finance.yahoo.comTivic Health Announces 2025 Annual Meeting of StockholdersJune 24, 2025 | finance.yahoo.comTivic Health sets new deadlines for stockholder proposalsMay 21, 2025 | investing.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTIVC, MHUA, FEMY, and CODX Company DescriptionsCo-Diagnostics NASDAQ:CODX$0.34 0.00 (-0.84%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$0.35 +0.01 (+2.90%) As of 09/12/2025 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.Femasys NASDAQ:FEMY$0.39 +0.03 (+6.84%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$0.39 0.00 (-0.54%) As of 09/12/2025 07:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Femasys Inc., a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs worldwide. The company provides FemVue saline-air device, a contrast-generating product in the United States, Canada, Japan, and Hong Kong; FemCath, a cornual balloon catheter, a single intrauterine directional delivery product that allows for selective evaluation of an individual fallopian tube; and FemCerv, a biopsy device for endocervical curettage, which can be used to sample cervical cells and tissue circumferentially with sample containment within the device to minimize contamination. It also develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. The company offers its products to reproductive endocrinologists for infertility products, obstetrics-gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.Meihua International Medical Technologies NASDAQ:MHUA$0.48 +0.06 (+13.86%) Closing price 09/12/2025 03:59 PM EasternExtended Trading$0.46 -0.03 (-5.56%) As of 09/12/2025 07:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Meihua International Medical Technologies Co., Ltd. engages in the manufacture, sells, and marketing of medical consumables in the People's Republic of China. The company offers class I, II, and III disposable medical devices. Its products include non-bottled products, such as brushes and ID bracelets; and polyethylene bottled products, such as eye drop and tablet bottles, as well as electronic pumps. The company also distributes disposable medical devices sourced from other manufacturers to customers in China. In addition, it offers COVID-19 products comprising disposable medical masks. The company serves hospitals, pharmacies, medical institutions, and medical equipment companies. It also exports its products to Europe, North America, South America, Asia, Africa, and Oceania. The company was founded in 1991 and is based in Yangzhou, the People's Republic of China. Meihua International Medical Technologies Co., Ltd. operates as a subsidiary of Bright Accomplish Limited.Tivic Health Systems NASDAQ:TIVC$3.11 +0.04 (+1.30%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$3.10 -0.01 (-0.48%) As of 09/12/2025 07:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Tivic Health Systems Inc. operates as a health tech company, focuses on developing and commercializing bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, such as BestBuy and FSAStore and through distributors. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 09/08 - 09/12 Meta's $600B U.S. Investment: Bearish or Bullish for Shares? Football Season Is Here and DraftKings Stock Is Surging RH Stock Slides After Mixed Earnings and Tariff Concerns Post Onum Deal: Is CrowdStrike Ready to Rebound After 16% Drop? Chewy’s September Pullback: Is It Your Time to Buy? It’s Time to Buy the Dip in Kroger Stock Price Is Coupang the Next MercadoLibre? A Playbook for Global Dominance Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
